Clinical Research

Bristol-Myers Squibb considers requests for research from all therapeutic areas, and gives priority to proposals that support our medical plans in the following therapeutic areas: cardiovascular/metabolics, neuroscience, cancer, immunology and virology.


Objectives

The Bristol-Myers Squibb ISR application process provides a framework and allows investigators to work from a common set of criteria, requirements and schedule of events. The process is designed to ensure scientific rigor and patient safety while supporting unique research ideas and providing insights into areas of unmet medical need.

Disclaimer

Requests for Research Proposals are not to be interpreted as suggesting that any product is safe or effective for an investigational use or recommended for any use outside of its approved labeling. Bristol-Myers Squibb does not guarantee support. Please note that studies may be submitted for “drug-only” support as well as drug & funding support. Support is solely recognized at the time of full execution of the clinical research agreement.


Therapeutic Area Products
Cardiovascular Apixaban Partnered with Pfizer
Apixaban is currently only accepting concepts for venous thromboembolism
Metabolics ONGLYZA™ (saxagliptin) Partnered with AstraZeneca
Dapagliflozin Partnered with AstraZeneca
Immunoscience Nulojix® (belatacept)
ORENCIA® (abatacept)
Oncology Brivanib
SPRYCEL® (dasatinib)
YERVOY™ (ipilimumab)
Virology REYATAZ® (atazanavir sulfate)
BARACLUDE®

Click here for trademark information on Bristol-Myers Squibb products.

Please click here to agree and return to a saved application.